Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Deaglio S.,,Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) on myeloma cells,2001,Leukemia Research,57,10.1016/S0145-2126(00)00105-3,Italy,Article,Turin,0,Journal,2-s2.0-0035132207
Cohen M.H.,,"Drug approval summaries: Arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene",2001,Oncologist,82,10.1634/theoncologist.6-1-4,United States,Review,Rockville,0,Journal,2-s2.0-0035135374
Jiang X.H.,,Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3,2001,International Journal of Cancer,138,10.1002/1097-0215(200002)9999:9999<::AID-IJC1039>3.0.CO;2-D,Hong Kong,Article,Pokfulam,1,Journal,2-s2.0-0035863397
Seol J.G.,,Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.,2001,International journal of oncology,48,10.3892/ijo.18.2.249,South Korea,Article,Seoul,0,Journal,2-s2.0-0035257262
Shen Y.,,Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: A comparison with conventional dosage,2001,Leukemia,124,10.1038/sj.leu.2402106,China,Article,Shanghai,1,Journal,2-s2.0-0035007005
Jing Y.,,Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo,2001,Blood,169,10.1182/blood.V97.1.264,United States,Article,New York,0,Journal,2-s2.0-0035161286
Ohnishi K.,,Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia,2000,Annals of Internal Medicine,180,10.7326/0003-4819-133-11-200012050-00012,Japan,Article,Hamamatsu,0,Journal,2-s2.0-0034610263
Uslu R.,,Arsenic trioxide-mediated cytotoxicity and apoptosis inprostate and ovarian carcinoma cell lines,2000,Clinical Cancer Research,179,,Turkey,Article,Izmir,0,Journal,2-s2.0-0034490080
Wang Z.,,Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia,2000,Lancet Oncology,60,10.1016/S1470-2045(00)00017-6,China,Review,Shanghai,0,Journal,2-s2.0-0034308663
Huang S.,,Induction of mitosis-mediated apoptosis by sodium arsenite in HeLa S3 cells,2000,Biochemical Pharmacology,38,10.1016/S0006-2952(00)00397-X,Taiwan,Article,Taipei,0,Journal,2-s2.0-0034666696
Rego E.,,Retinoic acid (RA) and As<inf>2</inf>O<inf>3</inf> treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARa and PLZF-RARα oncoproteins,2000,Proceedings of the National Academy of Sciences of the United States of America,162,10.1073/pnas.180290497,United States,Article,New York,1,Journal,2-s2.0-0034730198
Brenner C.,,Mitochondria - The death signal integrators,2000,Science,314,10.1126/science.289.5482.1150,France,Review,Compiegne,0,Journal,2-s2.0-0034682695
Costantini P.,,Mitochondrion as a novel target of anticancer chemotherapy,2000,Journal of the National Cancer Institute,467,10.1093/jnci/92.13.1042,France,Review,Paris,1,Journal,2-s2.0-0034608786
Kitamura K.,,Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all- trans retinoic acid,2000,British Journal of Haematology,86,10.1046/j.1365-2141.2000.01933.x,Japan,Article,Nagoya,1,Journal,2-s2.0-0034030355
Costantini P.,,Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis,2000,Oncogene,253,10.1038/sj.onc.1203299,France,Article,Paris,1,Journal,2-s2.0-0034642510
Ohsawa M.,,Arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) gradually downregulates tissue factor expression without affecting thrombomodulin expression in acute promyelocytic leukemia cells [1],2000,Leukemia,5,10.1038/sj.leu.2401755,Japan,Letter,Tokyo,1,Journal,2-s2.0-0033625035
Lin C.,,Successful Treatment of All-Trans Retinoic Acid Resistant and Chemotherapy Naive Acute Promyelocytic Patients with Arsenic Trioxid-e - Two Case Reports,2000,Leukemia and Lymphoma,10,10.3109/10428190009060333,China,Article,Taipei,0,Journal,2-s2.0-0034007827
Zhang T.,,"Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As<inf>2</inf>O<inf>3</inf>)",2000,Modern Pathology,20,10.1038/modpathol.3880174,United States,Article,Indianapolis,0,Journal,2-s2.0-0033799995
Lin C.P.,,Retinoic acid syndrome induced by arsenic Trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia,2000,Leukemia and Lymphoma,23,10.3109/10428190009060334,,Article,,0,Journal,2-s2.0-0034050085
Kinjo K.,,Arsenic trioxide (As<inf>2</inf>O<inf>3</inf>)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice,2000,Leukemia,50,10.1038/sj.leu.2401646,Japan,Article,Tokyo,1,Journal,2-s2.0-0033621843
McCabe J.,,"Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase",2000,Journal of Pharmacology and Experimental Therapeutics,56,,United States,Article,Rochester,0,Journal,2-s2.0-0033781987
Huff J.,,Is the human carcinogen arsenic carcinogenic to laboratory animals?,2000,Toxicological Sciences,64,10.1093/toxsci/55.1.17,United States,Review,Research Triangle Park,1,Journal,2-s2.0-0034024905
Kitamura K.,,Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis,2000,Leukemia,120,10.1038/sj.leu.2401900,Japan,Article,Nagoya,1,Journal,2-s2.0-0033779445
Camacho L.,,Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide,2000,Journal of Clinical Oncology,136,10.1200/JCO.2000.18.13.2620,United States,Article,New York,0,Journal,2-s2.0-0033916673
Cai X.,,Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia,2000,Leukemia,243,10.1038/sj.leu.2401650,China,Article,Shanghai,1,Journal,2-s2.0-0033974883
Niu C.,,"Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients",1999,Blood,496,10.1182/blood.v94.10.3315.422k16_3315_3324,,Article,,0,Journal,2-s2.0-0033570955
Jing Y.,,Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway,1999,Blood,506,10.1182/blood.v94.6.2102,United States,Article,New York,0,Journal,2-s2.0-0033568238
Slack J.,,Current issues in the management of acute promyelocytic leukemia,1999,Annals of Hematology,39,10.1007/s002770050585,United States,Review,Buffalo,0,Journal,2-s2.0-0342368618
Akao Y.,,Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro,1999,FEBS Letters,177,10.1016/S0014-5793(99)00841-8,Japan,Article,Kakamigahara,1,Journal,2-s2.0-0033066323
Huang C.,,Complete atrioventricular block after arsenic trioxide treatment in an acute promyelocytic leukemic patient,1999,PACE - Pacing and Clinical Electrophysiology,35,10.1111/j.1540-8159.1999.tb06826.x,Taiwan,Article,Taipei,0,Journal,2-s2.0-0032970336
Agis H.,,Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia,1999,Annals of Hematology,27,10.1007/s002770050523,Austria,Article,Vienna,0,Journal,2-s2.0-0032866226
Huang C.,,"Arsenic induces apoptosis through a c-Jun NH<inf>2</inf>-terminal kinase- dependent, p53-independent pathway",1999,Cancer Research,184,,United States,Article,Austin,0,Journal,2-s2.0-0033168034
Larochette N.,,Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore,1999,Experimental Cell Research,279,10.1006/excr.1999.4519,France,Article,Paris,0,Journal,2-s2.0-0033563729
Melnick A.,,"Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia",1999,Blood,893,10.1182/blood.v93.10.3167.410k44_3167_3215,United States,Review,New York,0,Journal,2-s2.0-0033561797
Kroemer G.,,"Arsenic trioxide, a novel mitochondriotoxic anticancer agent?",1999,Journal of the National Cancer Institute,81,10.1093/jnci/91.9.743,France,Editorial,Paris,1,Journal,2-s2.0-0033526398
Zhu X.H.,,Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations,1999,Journal of the National Cancer Institute,262,10.1093/jnci/91.9.772,,Article,,1,Journal,2-s2.0-0033526358
Lallemand-Breitenbach V.,,Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia,1999,Journal of Experimental Medicine,246,10.1084/jem.189.7.1043,,Article,,1,Journal,2-s2.0-0033526012
Tamm I.,,Treatment of acute promyelocytic leukemia with arsenic trioxide [2] (multiple letters),1999,New England Journal of Medicine,16,10.1056/NEJM199904013401313,United States,Letter,San Diego CA,0,Journal,2-s2.0-0033114763
Li Y.,,Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells,1999,Cancer Research,220,,United States,Article,Manhasset,0,Journal,2-s2.0-0000928694
Koken M.,,"Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)q23;q21) APL patient",1999,Oncogene,85,10.1038/sj.onc.1202414,France,Article,Paris,1,Journal,2-s2.0-0033611572
Galimberti S.,,Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia,1999,Bone Marrow Transplantation,16,10.1038/sj.bmt.1701875,Italy,Article,Pisa,1,Journal,2-s2.0-0032792110
Warrell R.,,Arsenicals and inhibitors of histone deacetylase as anticancer therapy.,1999,Haematologica,21,,United States,Review,New York,0,Journal,2-s2.0-0033139470
Tallman M.S.,,The thrombophilic state in acute promyelocytic leukemia,1999,Seminars in Thrombosis and Hemostasis,23,10.1055/s-2007-994922,United States;United States,Review,Chicago;Chicago,0,Journal,2-s2.0-0032934735
Giannì M.,,"In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARα protein and the PML retargeting on PML-nuclear bodies",1999,Leukemia,37,10.1038/sj.leu.2401419,Italy;France,Article,Milan;Paris,1,Journal,2-s2.0-0344327127
Zhu J.,,"Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents",1999,Leukemia,58,10.1038/sj.leu.2401448,China,Article,Shanghai,1,Journal,2-s2.0-20244379554
Shen Z.Y.,,Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro,1999,International Journal of Molecular Medicine,66,10.3892/ijmm.4.1.33,China,Article,Shantou,0,Journal,2-s2.0-0033159017
Sternsdorf T.,,PIC-1/SUMO-1-modified PML-retinoic acid receptor α mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia,1999,Molecular and Cellular Biology,88,10.1128/mcb.19.7.5170,Germany,Article,Hamburg,1,Journal,2-s2.0-0033037274
Dai J.,,Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system,1999,Blood,512,10.1182/blood.v93.1.268,United States,Article,New York,0,Journal,2-s2.0-0032933610
Huang S.,,Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia,1998,British Journal of Haematology,97,10.1046/j.1365-2141.1998.01079.x,Taiwan,Article,Taipei,1,Journal,2-s2.0-0032424777
Gallagher R.,,Arsenic - New life for an old potion,1998,New England Journal of Medicine,62,10.1056/NEJM199811053391909,United States,Editorial,New York,0,Journal,2-s2.0-0032487940
Soignet S.,,Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide,1998,New England Journal of Medicine,1050,10.1056/NEJM199811053391901,United States,Article,New York,0,Journal,2-s2.0-0032487923
Chen Y.,,Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis,1998,Journal of Cellular Physiology,404,10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9,Taiwan,Article,Taipei,0,Journal,2-s2.0-0031657760
Wang Z.G.,,Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARα independent manner,1998,Blood,223,10.1182/blood.v92.5.1497,,Article,,0,Journal,2-s2.0-0032170898
Giannì M.,,Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells,1998,Blood,144,10.1182/blood.v91.11.4300,,Article,,0,Journal,2-s2.0-0032100453
Barbui T.,,The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia,1998,Blood,186,10.1182/blood.v91.9.3093.3093_3093_3102,Italy,Review,Bergamo,1,Journal,2-s2.0-0032079468
Look A.T.,,Arsenic and apoptosis in the treatment of acute promyelocytic leukemia,1998,Journal of the National Cancer Institute,39,10.1093/jnci/90.2.86,United States,Editorial,"Memphis TN,",1,Journal,2-s2.0-0032554052
Shao W.,,Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells,1998,Journal of the National Cancer Institute,316,10.1093/jnci/90.2.124,Canada,Article,Montreal,1,Journal,2-s2.0-0000531696
Müller S.,,Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus,1998,EMBO Journal,562,10.1093/emboj/17.1.61,France,Article,Paris,0,Journal,2-s2.0-0037498052
Zhang W.,,The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms,1998,Leukemia,157,10.1038/sj.leu.2401112,Japan,Article,Hamamatsu,1,Journal,2-s2.0-0031708772
Chen G.Q.,,Use of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) in the treatment of acute promyelocytic leukemia (APL): I. As<inf>2</inf>O<inf>3</inf> exerts dose-dependent dual effects on APL cells,1997,Blood,723,,China,Article,Shanghai,0,Journal,2-s2.0-0030610686
Shen Z.X.,,Use of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) in the treatment of acute promyelocytic leukemia (AFL): II. Clinical efficacy and pharmacokinetics in relapsed patients,1997,Blood,1233,,,Article,,0,Journal,2-s2.0-0030610687
Zhu J.,,Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia,1997,Proceedings of the National Academy of Sciences of the United States of America,366,10.1073/pnas.94.8.3978,China;France,Article,Shanghai;Paris,1,Journal,2-s2.0-0030890942
Kitamura K.,,Toxic effects of arsenic (As<sup>3+</sup>) and other metal ions on acute promyelocytic leukemia cells,1997,International Journal of Hematology,17,10.1016/s0925-5710(96)00547-6,Japan,Article,Nagoya,1,Journal,2-s2.0-0031081669
Kwong Y.L.,,Delicious poison: arsenic trioxide for the treatment of leukemia.,1997,Blood,85,10.1182/blood.v89.9.3487,,Letter,,1,Journal,2-s2.0-0031137591
Andre C.,,The PML and PML/RARα domains: From autoimmunity to molecular oncology and from retinoic acid to arsenic,1996,Experimental Cell Research,31,10.1006/excr.1996.0368,France,Article,Creteil,0,Journal,2-s2.0-0030589343
Chen G.Q.,,In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As<inf>2</inf>O<inf>3</inf>) in the treatment of acute promyelocytic leukemia: As<inf>2</inf>O<inf>3</inf> induces NB<inf>4</inf> cell apoptosis with downregulation of Bcl-2 expression and modulation of PML- RARα/PML proteins,1996,Blood,763,10.1182/blood.v88.3.1052.bloodjournal8831052,,Article,,1,Journal,2-s2.0-0010740572
Mervis J.,,Ancient remedy performs new tricks,1996,Science,38,10.1126/science.273.5275.578,,Note,,0,Journal,2-s2.0-0029772547
